AXT (AXTI) Stock Jumps As AI Demand Fuels Profit Revival

AXT went into this print with a bruised share chart and a rich reputation, then ripped 28.7% higher to US$60.43 in a single session. The move followed a clear headline. The engineered materials company turned in record Q2 revenue of US$47.6m and swung back into profit with basic earnings per share of US$0.18.

For a stock that had fallen 37% over the past three months before this jump, the surprise is less about hype and more about cash generation finally catching up to the high expectations already baked into AXT’s lofty valuation.

Love the snap back to profit at AXT but remain concerned about paying up for rich expectations. Check out the 20 high quality undiscovered gems.

Q2 2026 Earnings Summary

• Revenue (Q2 2026 vs Q2 2025): US$47.589m vs. US$17.974m (very large increase, around 2.6x)
• Net Income (Excl. Extra Items, Q2 2026 vs Q2 2025): profit of US$11.128m vs. loss of US$7.052m (swing back into profit)
• Basic EPS (Q2 2026 vs Q2 2025): US$0.1817 vs. loss of US$0.1613 per share (return to positive earnings per share)
• Non GAAP Gross Margin (Q2 2026 vs Q2 2025): 45.0% vs. 8.2% (sharp margin expansion driven by higher volume and richer product mix)

Prefer clean charts over pages of raw earnings figures and margins for AXT? See the full visual view of AXT’s financial picture, with a focus on valuation and how the market is pricing this latest profit swing, in our company report for AXT.

AXT’s AI Substrate Story Hits Key Operating Marks

The bullish pitch on AXT has been that AI and cloud optics would turn indium phosphide into the real profit engine. Q2 points squarely in that direction. InP revenue reached US$30.7m out of US$47.6m total, which lines up with the idea that AI data center demand is now driving the bulk of the business. Non GAAP gross margin at 45.0% and the swing to an US$11.9m non GAAP net profit show that volume and mix are finally supporting the margin uplift the thesis has been waiting for.

That thesis also leans on visibility and capacity. Record backlog above US$100m, new long term supply agreements with Lumentum, Coherent and Casela, and large customer prepayments tie real contracts and cash to the AI story. The planned InP capacity expansions now rest on a US$748.8m cash and investment position, rather than hope alone.

Compare that surge in AXT’s margins, backlog and cash to what the street is pricing in right now. See the consensus price target analysis for AXT to gauge how closely analyst targets line up with this earnings bounce.

AXT bear case on execution and risk still unresolved

The bearish view on AXT is that heavy China exposure, export controls and complex execution on a big capacity build could derail the AI substrate story and keep results volatile. Q2 hits some key bear milestones in a positive way. Revenue of US$47.6m with US$30.7m from indium phosphide shows that backlog is converting and that InP, or indium phosphide, is functioning as the core profit engine rather than an aspirational slide.

However, several bear concerns remain untested or only partially addressed. Management still relies on timely export permits to reach the US$66m Q3 revenue that is described as “comfortable,” so regulatory friction is not disproved. Tongmei’s switch to a Hong Kong listing has triggered potential redemptions, which keeps financing risk alive despite US$748.8m of cash and investments. The long list of capacity plans also heightens future execution and utilization risk rather than putting it to bed.

After a quarter that leans so heavily on export permits, capacity build out and capital market moves, it may be worth asking if the current issues around volatility, dilution and insider selling are just the visible risks. Review our independent risk analysis for AXT which shows 3 important warning signs

Stay Ahead On AXT And Beyond

If AXT’s sharp swing back to profit and richer margins has your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch for a potential entry point. After you decide to take a position, use the Portfolio Command Center to cut through noise and keep focused on the key updates that matter to your holdings. For a broader view, tap into crowd insights and different angles on AXT and other stocks through the Community. By spotting hidden catalysts and risks early, you give yourself a better chance of staying ahead of the market.

Curious About Alternatives Beyond AXT?

Fresh ideas can move quickly as momentum builds, then get caught once the crowd piles in. Scan curated stock shortlists while it matters and get in early.

• Spot potential breakouts with strong balance sheets and resilient earnings trends by reviewing the curated list of solid balance sheet and fundamentals stocks (46 results) before they stop flying under the radar.
• Chase income opportunities that may hold up when growth stocks are dropping by scanning our hand picked 9 dividend fortresses while yields and coverage still look appealing.
• Hunt for potential multi year compounders hiding in plain sight by checking the tightly filtered 20 high quality undiscovered gems before crowd momentum catches up.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com